Moderna and Merck say melanoma vaccine succeeded in large trial

By Meg Tirrell, Jamie Gumbrecht, and Reuters (CNN) — A personalized mRNA cancer vaccine combined with the immunotherapy Keytruda succeeded in a late-stage trial for the deadly skin cancer melanoma, its makers said Wednesday, potentially opening up a new way of treating the disease. The study is ongoing, but interim results found that the treatment,